https://scholars.lib.ntu.edu.tw/handle/123456789/413440
標題: | The Use and the Prescription Pattern of Traditional Chinese Medicine among Urolithiasis Patients in Taiwan: A Population-Based Study | 作者: | Lin P.-H. Lin S.-K. Hsu R.-J. KUAN-CHEN CHENG Liu, Jui-Ming |
公開日期: | 2016 | 卷: | 22 | 期: | 1 | 起(迄)頁: | 88-95 | 來源出版物: | Journal of Alternative and Complementary Medicine | 摘要: | Objectives: To investigate the pattern of Traditional Chinese Medicine (TCM) usage for urolithiasis patients in Taiwan and to determine the most common Chinese herbal products used for urolithiasis. Design: Retrospective review of urolithiasis patients treated with TCM treatment. Settings/Location: One million randomly selected samples in the Taiwanese National Health Insurance Research Database between 1997 and 2008. Patients: Eighty-two thousand five hundred and fifty-one newly diagnosed urolithiasis patients. Outcome measures: The correlation between TCM treatment, demographic factors, or medical conditions. Results: A total of 62.6% of urolithiasis patients use TCM treatment. A younger age, female gender, polypharmacy, multiple comorbidities, and stone in the lower urinary tract result in a greater tendency to use TCM, after adjusting for demographic factors. Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder are the most frequently prescribed Chinese medicine formulae. Conclusion: This is the first study to examine the use of and the prescription pattern for TCM in urolithiasis patients using a random, national population-based sample. More than 62% of urolithiasis patients use TCM, and patients with polypharmacy, multiple comorbidities, and stone in the ureter are more likely to use TCM. The most frequently prescribed Chinese medicine formulae were Jia-Wei-Xiao-Yao-San Extract Powder and Ji-Sheng-Shen-Qi-Wan Extract Powder, which were reported to retard the progression of renal failure and alleviate flank pain or tenderness. ? Copyright 2016, Mary Ann Liebert, Inc. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/413440 | ISSN: | 10755535 | DOI: | 10.1089/acm.2015.0116 | SDG/關鍵字: | allopurinol; alpha adrenergic receptor blocking agent; Ba Zheng San extract powder; benzbromarone; citrate potassium; Dang Gui Shao Yao San extract powder; diclofenac; Gui Zhi Fu Ling Wan extract powder; herbaceous agent; ibuprofen; indometacin; Ji Sheng Shen Qi Wan extract powder; Jia Wei Xiao Yao San extract powder; Liu Wei Di Huang Wan extract powder; Long Dan Xie Gan Tang extract powder; mefenamic acid; scopolamine butyl bromide; sulindac; unclassified drug; urinary tract agent; Wu Ling San extract powder; Zhi Bai Di Huang Wan extract powder; Zhu Ling Tang extract powder; herbaceous agent; adolescent; adult; aged; Article; Chinese medicine; comorbidity; drug use; drug utilization; female; human; major clinical study; male; polypharmacy; population research; prescription; priority journal; Taiwan; urolithiasis; child; Chinese medicine; infant; middle aged; newborn; preschool child; retrospective study; urolithiasis; utilization; young adult; Adolescent; Adult; Aged; Child; Child, Preschool; Drugs, Chinese Herbal; Female; Humans; Infant; Infant, Newborn; Male; Medicine, Chinese Traditional; Middle Aged; Retrospective Studies; Taiwan; Urolithiasis; Young Adult |
顯示於: | 生物科技研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。